And while there's the possibility that they will soar while these two drop, assuming they all perform relatively similarly in the next few months, Microsoft will get there first simply because it's the closest. However, Microsoft has an excellent chance of performing better than, at the very least, its closest competitor, Apple. The iPhone maker has been hit hard this year due to the current U.S. administration's trade policies. The Trump administration aims to bring manufacturing back to the United States, ...

For several years, I worked as an equity analyst at a long-short hedge fund, with around $600 million in assets under management. While our long book would be larger than our short book, we would be short many more stocks than we would be long in. Typically, we might hold around 15 core long positions, while we could be short more than 70 stocks. The reason for this was quite simple. On the long side, we typically had a more concentrated portfolio in highly researched names that we had high conviction in. H ...

创新药周报20250713： 证券研究报告 证券分析师刘浩 执业编号：S0360520120002 邮箱：liuhao@hcyjs.com 联系人段江瑶 邮箱：duanjiangyao@hcyjs.com @2021 华创版权所有 第一部分 本周创新药重点关注 国内创新药回顾 02 全球首个口服HAE急性发作按需治疗药物获批上市 本报告由华创证券有限责任公司编制 卖的出价或询价。本报告所载信息均为个人观点，并不构成对所涉及证券的个人投资建议。 请仔细阅读PPT后部分的分析师声明及免责声明。 2025-07-13 全球新药速递 03 01 遗传性血管性水肿（HAE） 证券研究报告 致。 ┃ HAE诊断流程 ┃ HAE分型及特征 | HAE 分型 | 发病机制 | C1-INH 浓度 | CI-INH 功能 | | --- | --- | --- | --- | | HAE-C1-INH 1 型 | C1-INH 基因突变 | 降低 | 降低 | | HAE-C1-INH2 型 | C1-INH 基因突变 | 正常或增高 | 障低 | | HAE-nC1-INH | FXII、 ANGPTI、PLG 基因突变 | ...

Group 1 - The article discusses the closed-end fund (CEF) market activity, providing insights from both individual fund news and broader market trends [1] - It highlights the importance of yield and risk management in the construction of income portfolios [1] - The article promotes the use of Interactive Investor Tools for navigating various financial markets, including BDC, CEF, OEF, preferred, and baby bond markets [1] Group 2 - The article encourages readers to explore investor guides related to CEFs, preferreds, and PIMCO CEFs [2] - It offers a no-risk opportunity for potential investors to sign up for a 2-week free trial [2]

Core Insights - Nvidia holds a dominant position in the AI infrastructure market, particularly in the GPU sector, with over 90% market share due to its CUDA software platform [1] - Nvidia's market cap recently reached $4 trillion, but its growth may slow down due to the law of large numbers, making it possible for AMD and Broadcom to outperform Nvidia in the next five years [2] Nvidia - Nvidia's data center revenue was $39.1 billion last quarter, reflecting significant growth but also indicating challenges in maintaining such rapid expansion [6][14] - The company has seen its data center revenue increase more than ninefold in two years, suggesting that sustaining this growth rate may become increasingly difficult [14] Advanced Micro Devices (AMD) - AMD is experiencing strong revenue growth and is beginning to capitalize on AI opportunities, particularly in AI inference, although it remains a distant second to Nvidia in the GPU market [4] - AMD's GPUs are being utilized by major AI model companies for daily inference workloads, and its ROCm software platform is considered adequate for inference tasks [5] - AMD's data center revenue was $3.7 billion last quarter, indicating that even modest market share gains could lead to significant growth [6] - AMD is also a leader in data center CPUs, which are essential as AI workloads expand, increasing demand for high-performance CPUs [7] - The UALink Consortium, formed by AMD and others, aims to develop an open standard for AI interconnects, potentially challenging Nvidia's proprietary technologies [8][9] Broadcom - Broadcom is not directly competing with Nvidia in the GPU market but is focusing on AI networking and custom AI chip design [10] - The company's AI networking revenue surged 70% last quarter, driven by the increasing demands of large AI clusters [10] - Broadcom is designing custom AI chips for hyperscalers, with potential revenue opportunities estimated between $60 billion to $90 billion by fiscal 2027 [12] - The acquisition of VMware enhances Broadcom's position in AI cloud environments, providing strong upselling opportunities for its Cloud Foundation platform [13] Conclusion - While Nvidia remains a strong player in the AI market, AMD and Broadcom are well-positioned for growth due to their smaller revenue bases and potential market share gains in AI-related sectors [15]

"SaaS is going away." ——Dave Park， Narada AI联合创始人兼CEO SaaS 是现代企业数字化的中枢，但它也有天然的缺陷： · 僵化 ： 无论多"定制化"，SaaS 本质上仍是通用软件模板，无法真正深入理解每个企业的独特 语境。 · 割裂 ： 企业使用成百上千个SaaS工具，信息孤岛和工具间摩擦越来越大。 · 人工驱动 ： 操作和决策依赖于人——人点击、人填表、人判断。 在AI时代，这些限制显得越来越过时。 二、AI Agent是下一代软件范式 在企业服务软件领域，这句话不啻为一次"宣战"。Dave Park 的话不是一个悲观预测，而是一场 范式革命的战斗号角。他和 Narada AI 正在押注未来：一个 由AI智能体（AI Agent）主导的企 业软件新时代。 一、SaaS的黄金时代正在终结 过去二十年，SaaS（Software as a Service）模式重塑了软件业。从 Salesforce、Zoom 到 Notion、Slack，企业购买、部署、使用软件的方式发生了根本性变化： 从购买许可证到订阅服 务，从部署在本地到托管在云端，从功能导向到用户体验优先。 ...

这是新消费智库第 2 6 6 6 期文章 新消费导读 . . . . . . 4. Giorgio Armani 与 KITH 再度联袂发布全新系列 继 2024 秋冬系列合作之后， Giorgio Armani 与纽约街头时尚品牌 KITH 再度携手，推出全新联名系列 "ESTATE" ，首次同时涵盖男 装与女装。 （ 时尚无国界 ） 5. HOKA 推出全新鞋款 一周新品 1. 简爱超级桶荔枝杨梅风味发酵乳新品上市 1. 简爱超级桶荔枝杨梅风味发酵乳新品上市 2. 茉莉奶白推出恋夏漂亮水系列 3. 三顿半携手迪士尼《疯狂动物城》推出最新产品系列 4. 古茗携手吴彦祖加码咖啡业务 5. 专业跑步品牌 SOAR 进军中国市场 6. 霸王茶姬全国首家茶苑主题店将开业 7. 南酸枣糕齐云山冲刺港股 IPO 8. 植物医生冲 IPO 9. 梦龙冰淇淋独立运营 10. CHALI 潮养系列上新 11. 白鹤酒造 跨界做美妆 12. 巴黎欧莱雅推出 AI 美容助手 13. 悦诗风吟正式关闭海外旗舰店 简爱超级桶荔枝杨梅风味发酵乳新品上市。新品精选优质荔枝杨梅原料，不含色素、明胶、果胶、防腐剂、复原乳、食用香精，采用 1 ...

Methode Electronics, Inc. is an american engineering company that specializes in the development and manufacture of mechatronic electronic components for industrial and transportation OEM customers. The main areas of activity of Methode are automotive systems, industrialHi there! I’m Narek, and I’ve been in the investment world for over six years. I started out as an equity analyst at European banks, digging into reports and learning how to spot value in the markets. I’ve worked across sectors — from teleco ...

医药生物 证券分析师 张静含 A0230522080004 zhangjh@swsresearch.com 李敏杰 A0230523070006 limj2@swsresearch.com 联系人 2025 年 07 月 13 日 本周医药上涨 1.8%，中方限制采 购欧盟医疗器械，默沙东百亿美元 获取 COPD 新药 看好 ——医药行业周报（2025/7/7-2025/7/11） 本期投资提示： 究 / 行 业 点 评 相关研究 《本周医药上涨 3.6%，创新药及高端器械 再迎支持政策，医保目录谈判正式启动， AZ/Summit 或达成超 150 亿美元交易 — —医药行业周报（2025/6/30- 2025/7/4）》 2025/07/06 《本周医药上涨 1.6%，医保目录调整将首 度纳入商保创新药目录，荣昌泰它西普完 成超 40 亿美元授权——医药行业周报 （2025/6/23-2025/6/27）》 2025/06/29 李敏杰 (8621)23297818× limj2@swsresearch.com 请务必仔细阅读正文之后的各项信息披露与声明 本研究报告仅通过邮件提供给 中庚基金 使用。1 行 ...

In today's market, while valuations are important, there are other factors impacting the movement of stocks, such as investment flows and sentiment. Part of this has to do with the rise of exchange-traded funds (ETFs), passive investing, and algorithmic trading. Understanding sentiment is important because it tells investors where flows are focused and what companies could be prone to big moves.The large brokerage Interactive Brokers recently released data showing the 25 hottest stocks on its platform. The ...